Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians aligned with the Trump administration. Evita Solutions is the second company to have an approved generic version of mifepristone. to expand the availability of abortion drugs is unconscionable." In a statement, HHS spokesperson Andrew Nixon told CBS News that the agency "has very limited discretion in deciding whether to approve a generic drug" and that "by law, the Secretary of Health and Human Services must approve an application if it demonstrates that the generic drug is identical to the brand-name drug." Approval of a second generic is unlikely to affect access to the pill, which is typically taken with another drug, misoprostol.